Livent announced that Arcadium Lithium plc, the new holding company of the combined group that will result from the proposed merger of Allkem and Livent, has now received all required pre-closing regulatory approvals in connection with the proposed merger of equals between Allkem and Livent. This includes antitrust approvals in Canada, China, Japan, South Korea and the U.S., as well as completion of investment screenings in Australia, the U.K. and the U.S. Allkem and Livent are targeting closing of the Transaction on January 4, 2024. The closing of the Transaction remains subject to approval by both Livent and Allkem shareholders, and Australian Court approval of the Scheme.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on LTHM:
- Allkem and Livent Receive All Required Regulatory Approvals Globally to Close Merger of Equals
- Largest borrow rate increases among liquid names
- Livent price target lowered to $35 from $45 at Loop Capital
- Livent price target lowered to $20 from $24 at BMO Capital
- Livent price target lowered to $29 from $32 at KeyBanc
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue